Evidence map›Paper›PMID 37492787›Full record

ArticleAME case reports2023

A woman with Sjogren's syndrome and a new diagnosis of Evans syndrome: a case report.

Michelle A Ghebranious, Joad Eseddi, Haidy Galous

Open access · diamondAbstract readCase Reports
In one paragraph

Article in AME case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michelle A GhebraniousDepartment of Internal Medicine, The University of Texas at Southwestern Medical Center, Dallas, TX, USA.
Joad EseddiDepartment of Internal Medicine, The University of Texas at Southwestern Medical Center, Dallas, TX, USA.
Haidy GalousDepartment of Internal Medicine, The University of Texas at Southwestern Medical Center, Dallas, TX, USA.
The University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evans syndrome (ES) is a rare disease characterized by the simultaneous or sequential development of autoimmune hemolytic anemia (AIHA) with immune thrombocytopenia (ITP), and less frequently autoimmune neutropenia. ES can be primary or secondary to another disease. Isolated immune cytopenias have been reported with Sjogren's syndrome (SS) in the past, but the association with ES has very rarely been reported. Case Description: We present a patient with a known history of SS who presented with mild bleeding symptoms, such as heavier menses and new ecchymoses. She was found to have a very low haptoglobin, spherocytes on peripheral smear, positive direct antiglobulin test, and positive eluate testing. The findings were consistent with severe ITP and AIHA, leading to a diagnosis of secondary ES. She was treated with high-dose steroids for 4 days concurrent with 2 days of intravenous immunoglobulin (IVIG) with marked improvement in her hematological function. She was discharged on a steroid taper and remained in remission at follow-up visits. Conclusions: Although ES is a rare presentation of autoimmune disease, it is associated with high mortality and necessitates prompt clinical identification and appropriate therapy selection. Further research is necessary to understand the associated clinical characteristics, determine prognosis, and provide management recommendations.

Indexed as

case reportEvans syndrome (ES)Sjogren’s

Identifiers

PMID37492787
PMCPMC10364030
OpenAlexW4384563602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.